SpringWorks Therapeutics Inc

SpringWorks Therapeutics Inc

SWTX

Market Cap$3.47B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
SpringWorks Therapeutics IncSpringWorks Therapeutics Inc-13.3--57%46.2-
$47.00

Target Price by Analysts

1.7% upsideSpringWorks Therapeutics Target Price DetailsTarget Price
$-35.93

Current Fair Value

177.8% downside

Overvalued by 177.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$3.47 Billion
Enterprise Value$3.41 Billion
Dividend Yield$0 (0%)
Earnings per Share$-3.48
Beta0.79
Outstanding Shares74,132,811

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-13.28
PEG40.71
Price to Sales46.2
Price to Book Ratio7.7
Enterprise Value to Revenue25.14
Enterprise Value to EBIT-11.54
Enterprise Value to Net Income-13
Total Debt to Enterprise0
Debt to Equity0.02

Revenue Sources

No data

Insider Trades

ESG Score

No data

About SpringWorks Therapeutics Inc